Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Heaney v. Genocea Biosciences, Inc. et al
Case Number:
1:17-cv-12168
Court:
Nature of Suit:
Judge:
Firms
-
February 12, 2018
Investors In Genocea Herpes-Drug Row Get Lead Counsel
A Massachusetts federal judge on Monday tapped Scott & Scott Attorneys at Law LLP and Levi & Korsinsky LLP to guide investors who have accused Genocea Biosciences Inc. of hiding its inability to finance ongoing trials for a genital herpes immunotherapy and thus blindsiding them when deciding to halt its drug development plans.
-
November 06, 2017
Genocea Hit With Securities Suit After Herpes-Drug Flop
Genocea Biosciences Inc. hid its inability to finance ongoing trials for a genital herpes immunotherapy, according to a proposed class action filed Friday in Massachusetts by investors who said they were blindsided by the company's decision to halt its drug development plans, which triggered a 76 percent stock drop.